ReviewThe World Allergy Organization journal2026
Non-syndromic hyper-IgE in children: A practical approach.
Review in The World Allergy Organization journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Reply to the Letter: "Non-Syndromic elevated IgE": In reply to: Özdemir Ö. Non-syndromic elevated IgE. World Allergy Organization Journal 2026; 19:101420. Concerning: Castagnoli R, Pecoraro L, Mastrorilli C, et al. Non-syndromic hyper-IgE in children: a practical approach. World Allergy Organization Journal 2026; 19(3):101346.The World Allergy Organization journal · 2026Article
- Non-syndromic elevated IgE.The World Allergy Organization journal · 2026Article
- Early-Onset Severe Atopic Dermatitis With Hyper-IgE Overlap in a Child With a Heterozygous FLG Variant: A Case Report.Sage open pediatricsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hyper-IgE, generally defined as serum IgE levels exceeding 2000 IU/mL, presents a common yet complex diagnostic challenge in pediatric practice. While elevated serum IgE are frequently observed in atopic conditions such as food allergy or atopic eczema, or parasitic infections, they may also signal underlying monogenic immunological diseases, specifically inborn errors of immunity (IEI) categorized under hyper-IgE syndrome (HIES). Distinguishing between common atopic diseases and HIES is essential, especially in children with early-onset, severe, or treatment-resistant presentations. This review focuses on non-syndromic causes of hyper-IgE in children, aiming to provide a practical, structured framework for clinicians. A broad array of conditions, including allergic diseases, infections, inflammatory disorders, malignancies, drug reactions, and environmental exposures, can result in elevated IgE levels. Given this wide differential, a systematic approach that incorporates detailed clinical history, physical examination, and targeted investigations is critical to guide diagnostic reasoning. To aid clinical decision-making, the authors propose a stepwise diagnostic algorithm that prioritizes common causes while also alerting clinicians to red flags suggestive of IEI or other rare conditions. This approach facilitates timely referral for immunologic or genetic evaluation when appropriate and minimizes unnecessary testing. Increased awareness of the diverse etiologies of hyper-IgE can improve diagnostic accuracy, enhance early intervention, and reduce morbidity. Future research should aim to refine diagnostic strategies, validate clinical algorithms, and develop standardized guidelines. Moreover, long-term data regarding characterization and subsequent follow-up of children with an isolated increase in serum IgE levels is fundamental to understanding the clinical and immunological trajectories of these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.